Ulysses Holdings Asset Manager Profile - aVenture Research
Ulysses Holdings is an investment firm specializing in growth-stage companies. While specific investment sizes are undisclosed, their participation in Series C rounds indicates a focus on later-stage investments in established businesses with proven models. The firm provides both financial backing and professional support to foster business growth.
Ulysses Holdings' portfolio includes Alloy Therapeutics, a biotechnology company that has raised $75 million in total funding. The firm's approach combines capital investment with hands-on professional support, aiming to add value beyond financial contributions and actively assist portfolio companies in their development and expansion.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.